Genocea Biosciences Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St indexes fall to two-week lows as rising bond yields, disappointing Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Genocea Biosciences (GNCA) Collaboration with Janssen Can Spark a Bigger Partnership - Stifel
January 4, 2022 10:14 AM ESTStifel analyst Benjamin J. Burnett reiterates a "Buy" rating on shares of Genocea Biosciences (NASDAQ: GNCA), following announcement of collaboration and option agreement with Janssen Biotech, Inc., one... More
